Bio Gene (Australia) Analysis
| BGT Stock | 0.04 0 6.06% |
Bio Gene Technology is overvalued with Real Value of 0.031 and Hype Value of 0.03. The main objective of Bio Gene stock analysis is to determine its intrinsic value, which is an estimate of what Bio Gene Technology is worth, separate from its market price. There are two main types of Bio Gene's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Bio Gene's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Bio Gene's stock to identify patterns and trends that may indicate its future price movements.
The Bio Gene stock is traded in Australia on Australian Securities Exchange, with the market opening at 09:50:00 and closing at 16:12:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Australia. Bio Gene is usually not traded on Christmas Day, Boxing Day, New Year 's Day, Australia Day, Australia Day ( substitute day ), Good Friday, Easter Monday, ANZAC Day. Bio Stock trading window is adjusted to Australia/Sydney timezone.
Bio |
Bio Stock Analysis Notes
About 43.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.01. Bio Gene Technology had not issued any dividends in recent years. For more info on Bio Gene Technology please contact BSC BSc at 61 3 9068 1062 or go to https://www.bio-gene.com.au.Bio Gene Technology Investment Alerts
| Bio Gene Technology had very high historical volatility over the last 90 days | |
| Bio Gene Technology has some characteristics of a very speculative penny stock | |
| Bio Gene Technology has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 18.32 K. Net Loss for the year was (2.41 M) with loss before overhead, payroll, taxes, and interest of (558.91 K). | |
| Bio Gene generates negative cash flow from operations | |
| About 43.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Bio-Gene Technology Showcases Innovations at NWR Virtual Healthcare Conference 2025 - TipRanks |
Bio Gene Thematic Classifications
In addition to having Bio Gene stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | ComputersUSA Equities from Computers industry as classified by Fama & French | |
 | ITInformation technology and IT services |
Bio Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.05 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bio Gene's market, we take the total number of its shares issued and multiply it by Bio Gene's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Management Efficiency
Bio Gene Technology has return on total asset (ROA) of (0.4961) % which means that it has lost $0.4961 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.9426) %, meaning that it generated substantial loss on money invested by shareholders. Bio Gene's management efficiency ratios could be used to measure how well Bio Gene manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Bio Gene's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 5 M in 2025, whereas Non Current Liabilities Total is likely to drop slightly above 19.3 K in 2025.Leadership effectiveness at Bio Gene Technology is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 25th of March, Bio Gene shows the Mean Deviation of 4.22, risk adjusted performance of 0.0324, and Downside Deviation of 8.08. Bio Gene Technology technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Bio Gene Technology Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Bio Gene middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Bio Gene Technology. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Bio Gene Outstanding Bonds
Bio Gene issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bio Gene Technology uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bio bonds can be classified according to their maturity, which is the date when Bio Gene Technology has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Bio Gene Predictive Daily Indicators
Bio Gene intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bio Gene stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.06 | |||
| Day Median Price | 0.035 | |||
| Day Typical Price | 0.035 | |||
| Price Action Indicator | 0.001 | |||
| Period Momentum Indicator | 0.002 |
Bio Gene Forecast Models
Bio Gene's time-series forecasting models are one of many Bio Gene's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bio Gene's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Bio Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Bio Gene prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bio shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bio Gene. By using and applying Bio Stock analysis, traders can create a robust methodology for identifying Bio entry and exit points for their positions.
Bio Gene is entity of Australia. It is traded as Stock on AU exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Bio Gene to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Additional Tools for Bio Stock Analysis
When running Bio Gene's price analysis, check to measure Bio Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Gene is operating at the current time. Most of Bio Gene's value examination focuses on studying past and present price action to predict the probability of Bio Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Gene's price. Additionally, you may evaluate how the addition of Bio Gene to your portfolios can decrease your overall portfolio volatility.